-
1 Comment
Livzon Pharmaceutical Group Inc is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Livzon Pharmaceutical Group Inc's total revenue rose by 24.2% to $3B since the same quarter in the previous year.
Its net income has increased by 11.5% to $293M since the same quarter in the previous year.
Finally, its free cash flow grew by 73.6% to $406M since the same quarter in the previous year.
Based on the above factors, Livzon Pharmaceutical Group Inc gets an overall score of 4/5.
ISIN | CNE0000002Y8 |
---|---|
Exchange | SHE |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
CurrencyCode | CNY |
Market Cap | 28B |
---|---|
PE Ratio | 15.03 |
Dividend Yield | 3.9% |
Target Price | 39.936 |
Beta | 0.41 |
Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty; and Urofollitropin for injection to treat anovulation and sufferers. It also provides Perospirone hydrochloride tablets to treat schizophrenia; Shenqi Fuzheng Injection to treat weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for treating lung and stomach cancer; anti-viral granules used for clearing heat, eliminating dampness, cooling blood, and detoxifying to treat upper respiratory tract infection and influenza; Tocilizumab injection to treat rheumatoid arthritis; and Recombinant SARSCoV-2 fusion protein vaccine used to prevent diseases caused by SARS-CoV-2 infection. In addition, the company offers antinuclear antibody test kit, used for the detection of common anti-nuclear and anti-antibodies in the autoimmune diseases; nucleic acid test kits for human immunodeficiency virus type 1; interferon-gamma release assays test kits, used to determine whether the human body is infected with Mycobacterium tuberculosis; diagnostic kit for IgM antibody to mycoplasma pneumonia. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000513.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025